Healthcare provider profile · identity verified

David Heal, M.D.

General Practice · MOROVIS, PR · NPI 1538124664

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	346	100
Rosuvastatin Calcium	Rosuvastatin Calcium	338	107
Omeprazole	Omeprazole	274	66
Atorvastatin Calcium	Atorvastatin Calcium	255	83
Amlodipine Besylate	Amlodipine Besylate	233	74
Metformin Hcl	Metformin Hcl	209	64
Pantoprazole Sodium	Pantoprazole Sodium	195	44
Alendronate Sodium	Alendronate Sodium	190	61
Famotidine	Famotidine	185	51
Lisinopril	Lisinopril	185	59
Montelukast Sodium	Montelukast Sodium	176	58
Diclofenac Potassium	Diclofenac Potassium	167	52
Losartan Potassium	Losartan Potassium	155	48
Hydrochlorothiazide	Hydrochlorothiazide	148	46
Levothyroxine Sodium	Levothyroxine Sodium	137	47
Tamsulosin Hcl	Tamsulosin Hcl	131	45
Synthroid	Levothyroxine Sodium	126	40
Simvastatin	Simvastatin	125	40
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	109	41
Meclizine Hcl	Meclizine Hcl	109	32
Glimepiride	Glimepiride	103	32
Diclofenac Sodium	Diclofenac Sodium	102	30
Cilostazol	Cilostazol	100	40
Diclofenac Sodium Er	Diclofenac Sodium	99	35
Clonazepam	Clonazepam	97	22
Tramadol Hcl	Tramadol Hcl	96	12
Fluticasone Propionate	Fluticasone Propionate	94	33
Sucralfate	Sucralfate	87	24
Dicyclomine Hcl	Dicyclomine Hcl	86	24
Metoprolol Succinate	Metoprolol Succinate	85	25
Pentoxifylline	Pentoxifylline	83	28
Nabumetone	Nabumetone	79	19
Trazodone Hcl	Trazodone Hcl	77	26
Trijardy Xr	Empaglifloz/Linaglip/Metformin	74	12
Enalapril Maleate	Enalapril Maleate	72	25
Temazepam	Temazepam	63	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	52
Furosemide	Furosemide	61	22
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	58	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	20
Sertraline Hcl	Sertraline Hcl	57	19
Glipizide	Glipizide	56	16
Albuterol Sulfate Hfa	Albuterol Sulfate	54	16
Finasteride	Finasteride	51	15
Clopidogrel	Clopidogrel Bisulfate	46	17
Latanoprost	Latanoprost	46	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	22
Hydralazine Hcl	Hydralazine Hcl	43	15
Allopurinol	Allopurinol	41	15
Azithromycin	Azithromycin	41	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Mupirocin	Mupirocin	38	23
Albuterol Sulfate	Albuterol Sulfate	35	32
Candesartan Cilexetil	Candesartan Cilexetil	35	11
Dexamethasone	Dexamethasone	35	28
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Irbesartan	Irbesartan	34	11
Metoprolol Tartrate	Metoprolol Tartrate	34	12
Atenolol	Atenolol	33	suppressed
Pregabalin	Pregabalin	32	suppressed
Carvedilol	Carvedilol	30	11
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Ezetimibe	Ezetimibe	28	12
Ibandronate Sodium	Ibandronate Sodium	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Metronidazole	Metronidazole	28	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Baclofen	Baclofen	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Ofloxacin	Ofloxacin	24	21
Donepezil Hcl	Donepezil Hcl	22	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	22	21
Farxiga	Dapagliflozin Propanediol	21	suppressed
Rivastigmine	Rivastigmine	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Naproxen	Naproxen	20	suppressed
Eliquis	Apixaban	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	19	suppressed
Mesalamine	Mesalamine	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Silver Sulfadiazine	Silver Sulfadiazine	18	14
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Linzess	Linaclotide	15	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	15
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Xarelto	Rivaroxaban	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Nitroglycerin	Nitroglycerin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	11	suppressed
Mupirocin	Mupirocin Calcium	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error